Ronald Pauli serves as Executive at NEOPHARM INC, where they oversee executive responsibilities. Since joining the company, Ronald Pauli has executed 10 insider transactions totaling $11.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 2, 2019 involved exercising options for 15,320 shares valued at $0.
Ronald Pauli currently holds 39,614 shares of NEOPHARM INC (NEOL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Pauli has been a net buyer of NEOL stock. They have purchased $11.2K and sold $0 worth of shares.
Ronald Pauli's most recent insider trade was on May 2, 2019, when they sold 15,320 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $25.99 |
| Discretionary |
| May 3, 2018 | HZNP | $52.6K | Payment | 3,790 | $13.87 | Discretionary |
| May 3, 2018 | HZNP | $0 | Option Exercise | 14,054 | $N/A | Discretionary |
| May 3, 2017 | HZNP | $56.9K | Payment | 3,763 | $15.12 | Discretionary |
| May 3, 2017 | HZNP | $0 | Option Exercise | 13,953 | $N/A | Discretionary |
| May 6, 2016 | HZNP | $0 | Option Exercise | 5,258 | $N/A | Discretionary |
| May 6, 2016 | HZNP | $19.0K | Payment | 1,418 | $13.41 | Discretionary |
| Feb 22, 2012 | SGNT | $0 | Award | 3,680 | $N/A | Discretionary |
| Oct 5, 2006 | NEOL | $11.2K | Purchase | 2,000 | $5.60 | Discretionary |